Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study

Abstract

A low dose of acarbose administered to obese patients with PCOS promotes a reduction in free androgen index and BMI and an increase in SHBG, with improvement of hirsutism and of the menstrual pattern, and is well tolerated by patients.